Walter M.  Rosebrough, Jr. net worth and biography

Walter Rosebrough, Jr. Biography and Net Worth

Director of Cooper Companies

Mr. Rosebrough currently serves as CEO Emeritus and Senior Advisor of STERIS plc (NYSE: STE), a global medical device business focused on infection prevention products and services. During his tenure as CEO of STERIS from 2007 to 2021, STERIS’s stock generated a 10-fold total return or an 18% annualized return compared with a 10% annualized return for the S&P 500, and the company’s market capitalization increased by over $20 billion. His career also includes nearly two decades at Hill-Rom Holdings, Inc., where he held senior executive positions, including President and CEO of Support Systems International and President and CEO of Hill-Rom. Mr. Rosebrough currently serves as Independent Chair on the Board of Varex Imaging (NASDAQ: VREX).

Mr. Rosebrough holds a Master of Business Administration from Stanford University, and a BIE from Kettering University.

What is Walter M. Rosebrough, Jr.'s net worth?

The estimated net worth of Walter M. Rosebrough, Jr. is at least $1.07 million as of September 14th, 2026. Mr. Rosebrough, Jr. owns 20,000 shares of Cooper Companies stock worth more than $1,065,400 as of September 16th. This net worth evaluation does not reflect any other assets that Mr. Rosebrough, Jr. may own. Learn More about Walter M. Rosebrough, Jr.'s net worth.

How do I contact Walter M. Rosebrough, Jr.?

The corporate mailing address for Mr. Rosebrough, Jr. and other Cooper Companies executives is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. Cooper Companies can also be reached via phone at (925) 460-3600 and via email at [email protected]. Learn More on Walter M. Rosebrough, Jr.'s contact information.

Has Walter M. Rosebrough, Jr. been buying or selling shares of Cooper Companies?

During the past quarter, Walter M. Rosebrough, Jr. has bought $541,640.00 in Cooper Companies stock. Most recently, on Monday, September 14th, Walter M. Rosebrough, Jr. bought 3,000 shares of Cooper Companies stock. The stock was acquired at an average cost of $54.29 per share, with a total value of $162,870.00. Following the completion of the transaction, the director now directly owns 20,000 shares of the company's stock, valued at $1,085,800. Learn More on Walter M. Rosebrough, Jr.'s trading history.

Who are Cooper Companies' active insiders?

Cooper Companies' insider roster includes Brian Andrews (CFO), Robert Auerbach (CEO), Paul Keel (Director), Lawrence Kurzius (Director), Jody Lindell (Director), Cynthia Lucchese (Director), Daniel McBride (COO), Gary Petersmeyer (Director), Agostino Ricupati (SVP), Maria Rivas (Director), Walter Rosebrough, Jr. (Director), Holly Sheffield (EVP), Gerard Warner, III (COO), Robert Weiss (Director), and Albert White, III (CEO). Learn More on Cooper Companies' active insiders.

Are insiders buying or selling shares of Cooper Companies?

In the last year, Cooper Companies insiders bought shares 10 times. They purchased a total of 42,715 shares worth more than $2,771,934.72. The most recent insider tranaction occured on September, 14th when Director Walter M. Rosebrough, Jr. bought 3,000 shares worth more than $162,870.00. Insiders at Cooper Companies own 2.1% of the company. Learn More about insider trades at Cooper Companies.

Information on this page was last updated on 9/14/2026.

Walter M. Rosebrough, Jr. Insider Trading History at Cooper Companies

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
9/14/2026Buy3,000$54.29$162,870.0020,000View SEC Filing Icon  
9/11/2026Buy7,000$54.11$378,770.0017,000View SEC Filing Icon  
See Full Table

Walter M. Rosebrough, Jr. Buying and Selling Activity at Cooper Companies

This chart shows Walter M. Rosebrough, Jr.'s buying and selling at Cooper Companies by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Cooper Companies Company Overview

Cooper Companies logo
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific. The CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage to health care professionals and patients worldwide. It offers surgical and office products, including endosee endometrial imaging products, fetal pillow cephalic elevation devices for use in cesarean sections, illuminated speculum products, lone star retractor systems, loop electrosurgical excision procedure products, mara water ablation systems, paragard contraceptive IUDs, point-of-care, and uterine positioning products, as well as cryostorage, such as cord blood and cord tissue storage; fertility products and services, such as fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Read More

Today's Range

Now: $53.27
Low: $52.97
High: $54.80

50 Day Range

MA: $70.88
Low: $53.27
High: $76.82

2 Week Range

Now: $53.27
Low: $51.01
High: $89.83

Volume

4,416,292 shs

Average Volume

3,236,123 shs

Market Capitalization

$10.13 billion

P/E Ratio

18.18

Dividend Yield

N/A

Beta

0.82